OSLIGLIP-M 1000 TABLETS
OSLIGLIP-M 1000 TABLETS
Composition: Teneligliptin 20mg + Metformin 1000mg Sustained Release
Additional Details:
Packing Size | 10×10 Alu-Alu |
Form | Tablet |
Brand Name: Osliglip-m 1000 Tablets
Description: A combination therapy for effective diabetes management.
Send Enquiry & Get Best Quote
OSLIGLIP-M 1000 TABLETS β Advanced Diabetes Management
Introduction to OSLIGLIP-M 1000 TABLETS
Diabetes is a chronic condition that affects millions worldwide, requiring consistent management to prevent severe complications. OSLIGLIP-M 1000 TABLETS is a combination of Teneligliptin 20mg and Metformin 1000mg (Sustained Release), designed to provide effective glycemic control for Type 2 Diabetes Mellitus (T2DM).
This dual-action therapy enhances insulin secretion, reduces glucose production, and improves insulin sensitivity, helping patients maintain stable blood sugar levels throughout the day. OSLIGLIP-M 1000 TABLETS is the preferred choice for individuals who need a powerful yet safe medication for long-term diabetes management.
Key Benefits of OSLIGLIP-M 1000 TABLETS
β Optimized Blood Sugar Control
β Effectively regulates fasting and postprandial glucose levels.
β Enhanced Insulin Sensitivity
β Improves body response to insulin, reducing insulin resistance.
β Sustained Release for Long-Lasting Effect
β Ensures consistent blood sugar control throughout the day.
β Prevents Sugar Spikes
β Controls after-meal sugar surges, reducing fluctuations.
β Supports Weight Management
β Helps maintain a healthy body weight, reducing obesity risks.
β Protects Heart & Kidney Health
β Lowers the risk of diabetes-related cardiovascular and renal complications.
β Reduces the Risk of Hypoglycemia
β Minimizes low blood sugar episodes, ensuring stability.
Composition of OSLIGLIP-M 1000 TABLETS
Each OSLIGLIP-M 1000 TABLET contains:
Ingredient | Function |
---|---|
Teneligliptin 20mg | A DPP-4 inhibitor that enhances insulin secretion and reduces glucose production. |
Metformin 1000mg (Sustained Release) | A biguanide that improves insulin sensitivity and slows glucose absorption for extended control. |
This combination ensures comprehensive diabetes management while protecting vital organs.
How OSLIGLIP-M 1000 TABLETS Work?
β Stimulates Insulin Secretion β Teneligliptin increases insulin production from pancreatic beta cells.
β Reduces Excess Sugar Formation β Suppresses glucose production in the liver, preventing sugar buildup.
β Delays Sugar Absorption β Metformin reduces glucose absorption in the intestines.
β Enhances Insulin Sensitivity β Ensures better utilization of insulin by muscle cells.
β Prevents Cardiovascular Risks β Reduces cholesterol levels and supports heart health.
β Sustained Release for Prolonged Action β Keeps blood sugar stable for an extended period.
Who Should Use OSLIGLIP-M 1000 TABLETS?
β
Individuals with Type 2 Diabetes Mellitus (T2DM) β Ensures superior blood sugar control.
β
Patients with Insulin Resistance β Helps enhance insulin sensitivity.
β
Diabetics at Risk of Heart Disease β Supports cardiovascular function.
β
Individuals Struggling with Post-Meal Sugar Spikes β Regulates postprandial glucose levels.
β
Patients Looking for Long-Lasting Sugar Control β Sustained-release formula provides extended benefits.
How to Use OSLIGLIP-M 1000 TABLETS?
π Dosage Guidelines:
β As prescribed by a healthcare professional.
β Take with a full glass of water.
β Consume after meals to reduce gastric discomfort.
β Do not crush or chew β sustained release tablets should be swallowed whole.
π For Best Results:
β Follow a balanced diet low in sugar and refined carbs.
β Engage in regular physical activity to improve insulin function.
β Monitor blood sugar levels regularly to assess medication effectiveness.
Precautions & Warnings
β Not suitable for Type 1 Diabetes or Diabetic Ketoacidosis patients.
β Avoid excessive alcohol consumption as it may lead to lactic acidosis.
β May cause mild digestive discomfort initially β consult a doctor if symptoms persist.
β Pregnant or breastfeeding women should use under medical supervision.
β Patients with severe kidney or liver issues should seek medical advice before use.
Why Choose OSLIGLIP-M 1000 TABLETS?
β
Clinically tested for superior Type 2 Diabetes control.
β
Dual-action therapy for long-term glycemic management.
β
Protects cardiovascular and kidney health.
β
Recommended by leading healthcare professionals.
β
Manufactured under stringent quality standards.
PCD Pharma Franchise for OSLIGLIP-M 1000 TABLETS
πΌ Osiante Biotech is offering PCD Pharma Franchise opportunities for OSLIGLIP-M 1000 TABLETS across India.
πΉ Why Partner with Us?
β Exclusive monopoly-based marketing rights.
β High-demand product with excellent clinical efficacy.
β Attractive profit margins and promotional support.
β Reliable supply chain and timely delivery.
Conclusion
OSLIGLIP-M 1000 TABLETS is an advanced dual-action therapy designed for effective Type 2 Diabetes control. With Teneligliptin and Metformin (Sustained Release), this medication ensures optimal glycemic control, reduced risk of heart and kidney complications, and improved overall health.
With scientific backing, minimal side effects, and proven efficacy, OSLIGLIP-M 1000 TABLETS is a trusted choice for individuals managing diabetes.
π Take control of your diabetes with OSLIGLIP-M 1000 TABLETS β Your Step Towards a Healthier Future! π©Έπͺ
How to Order OSLIGLIP-M 1000 TABLETS?
For bulk orders, franchise inquiries, or business collaborations, contact us with Osiante biotech and Chemo biological